US Patent Issued to Neumarker on Oct. 7 for "Predicting patient responses to multiple modalities of CNS disease interventions" (California Inventors)

ALEXANDRIA, Va., Oct. 8 -- United States Patent no. 12,433,527, issued on Oct. 7, was assigned to Neumarker Inc. (Palo Alto, Calif.).

"Predicting patient responses to multiple modalities of CNS disease interventions" was invented by Qing Wang (Palo Alto, Calif.) and Qiang Li (Saratoga, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "An electroencephalography (EEG) system comprises: an EEG device; a display; one or more processors; a memory; and one or more programs, wherein the one or more programs are stored in the memory and configured to be executed by the one or more processors, the one or more programs including instructions for: receiving measurement data; extracting, from the measurement data, a...